Marc Ferrante Department of Chronic Diseases and Metabolism (CHROMETA), Translational Research Center for Gastrointestinal Disorders (TARGID) KU Leuven Biography Publications Institution JoVE Articles Marc Ferrante has not added a biography. If you are Marc Ferrante and would like to personalize this page please email our Author Liaison for assistance. Publications Risankizumab As Maintenance Therapy for Moderately to Severely Active Crohn's Disease: Results from the Multicentre, Randomised, Double-blind, Placebo-controlled, Withdrawal Phase 3 FORTIFY Maintenance Trial Lancet (London, England). 05, 2022 | Pubmed ID: 35644155 Risankizumab As Induction Therapy for Crohn's Disease: Results from the Phase 3 ADVANCE and MOTIVATE Induction Trials Lancet (London, England). 05, 2022 | Pubmed ID: 35644154 Real-world Endoscopic and Histologic Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis Journal of Crohn's & Colitis. May, 2022 | Pubmed ID: 35533353 Longitudinal Monitoring of STAT3 Phosphorylation and Histologic Outcome of Tofacitinib Therapy in Patients with Ulcerative Colitis Alimentary Pharmacology & Therapeutics. Apr, 2022 | Pubmed ID: 35484689 Integrated Analysis of Microbe-host Interactions in Crohn's Disease Reveals Potential Mechanisms of Microbial Proteins on Host Gene Expression IScience. May, 2022 | Pubmed ID: 35479407 Patient-reported Continuous Clinical Response to Golimumab in Adults with Moderately to Severely Active Ulcerative Colitis: Results from GO OBSERVE, a Real-world European Observational Study European Journal of Gastroenterology & Hepatology. 06, 2022 | Pubmed ID: 35412484 In Memoriam: Emeritus Prof. Dr. Paul Rutgeerts (1948-2020) Gastroenterology. 05, 2022 | Pubmed ID: 35259344 Assessment of Endoscopic Disease Activity in Ulcerative Colitis: Is Simplicity the Ultimate Sophistication? Inflammatory Intestinal Diseases. Jan, 2022 | Pubmed ID: 35224012 Proctocolectomy and Ileal Pouch-anal Anastomosis for the Treatment of Collagenous Colitis Clinical Journal of Gastroenterology. Jun, 2022 | Pubmed ID: 35220554 Postoperative Crohn's Disease Recurrence: Time to Adapt Endoscopic Recurrence Scores to the Leading Surgical Techniques Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 06, 2022 | Pubmed ID: 35183769 Severe Necrotizing Colitis in a 45-Year-Old Woman Without a Cardiovascular History Gastroenterology. Feb, 2022 | Pubmed ID: 35149030 INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial Inflammatory Bowel Diseases. Jan, 2022 | Pubmed ID: 35099555 Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: a Multi-stakeholder Position Statement Highlighting the Need for Post-marketing Studies Journal of Crohn's & Colitis. Jan, 2022 | Pubmed ID: 35078228 Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: Unmet Needs and Future Perspectives The Lancet. Gastroenterology & Hepatology. 02, 2022 | Pubmed ID: 35026171 Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease Journal of Crohn's & Colitis. May, 2022 | Pubmed ID: 34664635 Inflammatory Bowel Disease-related Behaviours [IBD-Bx] Questionnaire: Development, Validation and Prospective Associations with Fatigue Journal of Crohn's & Colitis. May, 2022 | Pubmed ID: 34622275 Infliximab Concentrations During Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease Under Combination Therapy The Journal of Pediatrics. 01, 2022 | Pubmed ID: 34481805 Population Pharmacokinetic-pharmacodynamic Model-based Exploration of Alternative Ustekinumab Dosage Regimens for Patients with Crohn's Disease British Journal of Clinical Pharmacology. 01, 2022 | Pubmed ID: 34197653 Recent Advances in Clearance Monitoring of Monoclonal Antibodies in Patients with Inflammatory Bowel Diseases Expert Review of Clinical Pharmacology. Dec, 2021 | Pubmed ID: 35034509 Translating Results from VARSITY to Real World: Adalimumab Vs Vedolizumab As First-line Biological in Moderate to Severe IBD Inflammatory Bowel Diseases. Nov, 2021 | Pubmed ID: 34751766 Safety and Efficacy of Combining Biologics or Small Molecules for Inflammatory Bowel Disease or Immune-mediated Inflammatory Diseases: A European Retrospective Observational Study United European Gastroenterology Journal. 12, 2021 | Pubmed ID: 34694746 Chronic Antibiotic-Refractory Pouchitis: Management Challenges Clinical and Experimental Gastroenterology. 2021 | Pubmed ID: 34163205 Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study Journal of Crohn's & Colitis. Dec, 2021 | Pubmed ID: 34077509 Rectal Organoid Morphology Analysis (ROMA) As a Promising Diagnostic Tool in Cystic Fibrosis Thorax. 11, 2021 | Pubmed ID: 33859053 Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways Frontiers in Immunology. 2021 | Pubmed ID: 33790898 Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease Inflammatory Bowel Diseases. 10, 2021 | Pubmed ID: 33624092 Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus Frontiers in Pediatrics. 2021 | Pubmed ID: 33614555 The Effect of Aging on Infliximab Exposure and Response in Patients with Inflammatory Bowel Diseases British Journal of Clinical Pharmacology. 10, 2021 | Pubmed ID: 33604964 Positioning Strictureplasty in the Treatment of Extensive Crohn's Disease Ileitis: a Comparative Study with Ileocecal Resection International Journal of Colorectal Disease. Apr, 2021 | Pubmed ID: 33479821 Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD Journal of Crohn's & Colitis. 07, 2021 | Pubmed ID: 33341879 Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis Inflammatory Bowel Diseases. 05, 2021 | Pubmed ID: 33313682 Tissue Exposure Does Not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations Journal of Crohn's & Colitis. Jun, 2021 | Pubmed ID: 33245363 Thiopurine Monotherapy Has a Limited Place in Treatment of Patients with Mild-to-moderate Crohn's Disease Gut. 07, 2021 | Pubmed ID: 32928916 Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon Journal of Crohn's & Colitis. Mar, 2021 | Pubmed ID: 32915959 Endoscopic Remission Can Be Predicted by Golimumab Concentrations in Patients with Ulcerative Colitis Treated with the Changed Label European Journal of Gastroenterology & Hepatology. 01, 2021 | Pubmed ID: 32804854 Correction of CFTR Function in Intestinal Organoids to Guide Treatment of Cystic Fibrosis The European Respiratory Journal. 01, 2021 | Pubmed ID: 32747394 High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 08, 2021 | Pubmed ID: 32461138 Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 04, 2021 | Pubmed ID: 32272248 Current Use of Fecal Calprotectin in the Management of Patients With Inflammatory Bowel Disease Gastroenterology & Hepatology. Feb, 2020 | Pubmed ID: 34035707 Worries and Concerns of Inflammatory Bowel Disease (IBD) Patients in Belgium - a Validation of the Dutch Rating Form Scandinavian Journal of Gastroenterology. Dec, 2020 | Pubmed ID: 33135491 Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium Frontiers in Immunology. 2020 | Pubmed ID: 32983101 Ulcerative Colitis Nature Reviews. Disease Primers. 09, 2020 | Pubmed ID: 32913180 Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post Hoc Analysis of the SONIC Trial The American Journal of Gastroenterology. 08, 2020 | Pubmed ID: 32759621 Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis Cells. 07, 2020 | Pubmed ID: 32731480 2020 International Consensus on ANCA Testing Beyond Systemic Vasculitis Autoimmunity Reviews. Sep, 2020 | Pubmed ID: 32663621 Long-term Outcomes of Patients with Ulcerative Proctitis: Analysis from a Large Referral Centre Cohort United European Gastroenterology Journal. 10, 2020 | Pubmed ID: 32631177 Fibrogenesis in Chronic Murine Colitis is Independent of Innate Lymphoid Cells Immunity, Inflammation and Disease. 09, 2020 | Pubmed ID: 32567222 Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation Journal of Crohn's & Colitis. Dec, 2020 | Pubmed ID: 32556102 Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis Gastroenterology. 10, 2020 | Pubmed ID: 32474118 Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? Frontiers in Pharmacology. 2020 | Pubmed ID: 32457619 Gastroenterologists' Preference and Risk Perception on the Use of Immunomodulators and Biological Therapies in Elderly Patients with Ulcerative Colitis: an International Survey European Journal of Gastroenterology & Hepatology. 08, 2020 | Pubmed ID: 32453008 Early Postoperative Endoscopic Recurrence in Crohn's Disease Is Characterised by Distinct Microbiota Recolonisation Journal of Crohn's & Colitis. Nov, 2020 | Pubmed ID: 32333762 The Prevention and Management of Crohn's Disease Postoperative Recurrence: Results from the Y-ECCO/ClinCom 2019 Survey European Journal of Gastroenterology & Hepatology. 08, 2020 | Pubmed ID: 32282539 Development and Feasibility of a Telemonitoring Tool with Full Integration in the Electronic Medical Record: a Proof of Concept Study for Patients with Inflammatory Bowel Disease in Remission on Biological Therapy Scandinavian Journal of Gastroenterology. Mar, 2020 | Pubmed ID: 32180470 Editorial: a Clinical Decision Tool to Identify Patients Who Might Benefit Most from Intensified Dosing in the Biological Era-getting Nearer? Alimentary Pharmacology & Therapeutics. 04, 2020 | Pubmed ID: 32162373 Evaluating an Easy Sampling Method Using Dried Blood Spots to Determine Vedolizumab Concentrations Journal of Pharmaceutical and Biomedical Analysis. Jun, 2020 | Pubmed ID: 32151929 Automatic, Computer-aided Determination of Endoscopic and Histological Inflammation in Patients with Mild to Moderate Ulcerative Colitis Based on Red Density Gut. 10, 2020 | Pubmed ID: 31915237 Efficacy of JAK Inhibitors in Ulcerative Colitis Journal of Crohn's & Colitis. Aug, 2020 | Pubmed ID: 31879750 Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases Journal of Crohn's & Colitis. Jun, 2020 | Pubmed ID: 31875891 Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients Journal of Clinical Gastroenterology. 10, 2020 | Pubmed ID: 31789759 Long-term Outcome of Immunomodulator Use in Pediatric Patients with Inflammatory Bowel Disease Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 02, 2020 | Pubmed ID: 31640916 The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor Journal of Crohn's & Colitis. Feb, 2020 | Pubmed ID: 31628842 Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients Journal of Crohn's & Colitis. Mar, 2020 | Pubmed ID: 31504343 Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 05, 2020 | Pubmed ID: 31446181 Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center Inflammatory Bowel Diseases. 03, 2020 | Pubmed ID: 31400283 Outcome of Biological Therapies in Chronic Antibiotic-refractory Pouchitis: A Retrospective Single-centre Experience United European Gastroenterology Journal. 11, 2019 | Pubmed ID: 31700634 Inflammatory Bowel Disease (IBD)-A Textbook Case for Multi-Centric Banking of Human Biological Materials Frontiers in Medicine. 2019 | Pubmed ID: 31681784 Patient-derived Organoids from Endometrial Disease Capture Clinical Heterogeneity and Are Amenable to Drug Screening Nature Cell Biology. 08, 2019 | Pubmed ID: 31371824 Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13 Scientific Reports. 07, 2019 | Pubmed ID: 31296924 Short Health Scale: a Valid and Reliable Measure of Quality of Life in Dutch Speaking Patients with Inflammatory Bowel Disease Scandinavian Journal of Gastroenterology. May, 2019 | Pubmed ID: 31106617 Editorial: Biomarker Predictors of Non-response to TNFα Antagonists - the Quest Continues. Authors' Reply Alimentary Pharmacology & Therapeutics. 04, 2019 | Pubmed ID: 30920040 Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis Journal of Crohn's & Colitis. Sep, 2019 | Pubmed ID: 30919886 Clostridium Difficile Infection in Inflammatory Bowel Disease: Epidemiology over Two Decades European Journal of Gastroenterology & Hepatology. Jun, 2019 | Pubmed ID: 30839436 Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study Journal of Crohn's & Colitis. Sep, 2019 | Pubmed ID: 30820530 Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates Journal of Crohn's & Colitis. Jul, 2019 | Pubmed ID: 30715258 Low TREM1 Expression in Whole Blood Predicts Anti-TNF Response in Inflammatory Bowel Disease EBioMedicine. Feb, 2019 | Pubmed ID: 30685385 Mucosal IL13RA2 Expression Predicts Nonresponse to Anti-TNF Therapy in Crohn's Disease Alimentary Pharmacology & Therapeutics. 03, 2019 | Pubmed ID: 30663072 Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease Journal of Crohn's & Colitis. Jul, 2019 | Pubmed ID: 30657881 Impact of Endoscopy System, High Definition, and Virtual Chromoendoscopy in Daily Routine Colonoscopy: a Randomized Trial Endoscopy. 03, 2019 | Pubmed ID: 30646403 Optimising Infliximab Induction Dosing for Patients with Ulcerative Colitis British Journal of Clinical Pharmacology. 04, 2019 | Pubmed ID: 30634202 Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease Journal of Pediatric Gastroenterology and Nutrition. 06, 2019 | Pubmed ID: 30633108 Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease Therapeutic Drug Monitoring. 06, 2019 | Pubmed ID: 30633088 Immunogenicity is Not the Driving Force of Treatment Failure in Vedolizumab-treated Inflammatory Bowel Disease Patients Journal of Gastroenterology and Hepatology. Jul, 2019 | Pubmed ID: 30589948 Efficacy and Safety of Radiofrequency Ablation of Barrett's Esophagus in the Absence of Reimbursement: a Multicenter Prospective Belgian Registry Endoscopy. 04, 2019 | Pubmed ID: 30360011 Vedolizumab in Refractory Microscopic Colitis: An International Case Series Journal of Crohn's & Colitis. Mar, 2019 | Pubmed ID: 30329034 No Change in Determining Crohn's Disease Recurrence Or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring System Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 07, 2019 | Pubmed ID: 30291910 Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab Journal of Crohn's & Colitis. Jan, 2019 | Pubmed ID: 30281093 Edematous Colitis of an Unknown Cause, Diagnosis by Pattern Recognition Gastroenterology. 01, 2019 | Pubmed ID: 30205100 TREM-1, the Ideal Predictive Biomarker for Endoscopic Healing in Anti-TNF-treated Crohn's Disease Patients? Gut. 08, 2019 | Pubmed ID: 30007919 Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort Inflammatory Bowel Diseases. 01, 2019 | Pubmed ID: 29920582 Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease Frontiers in Immunology. 2018 | Pubmed ID: 30619339 Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information The AAPS Journal. 12, 2018 | Pubmed ID: 30564993 When IBD is Not IBD Scandinavian Journal of Gastroenterology. Sep, 2018 | Pubmed ID: 30256685 Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease Journal of Crohn's & Colitis. Nov, 2018 | Pubmed ID: 30239644 Influence of Early Adalimumab Serum Levels on Immunogenicity and Long-term Outcome of Anti-TNF Naive Crohn's Disease Patients: the Usefulness of Rapid Testing Alimentary Pharmacology & Therapeutics. 10, 2018 | Pubmed ID: 30109889 Failure of MMP-9 Antagonists in IBD: Demonstrating the Importance of Molecular Biology and Well-Controlled Early Phase Studies Journal of Crohn's & Colitis. Aug, 2018 | Pubmed ID: 30010739 Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study Inflammatory Bowel Diseases. 10, 2018 | Pubmed ID: 29788318 Efficacy of Vedolizumab for Induction of Clinical Response and Remission in Patients with Moderate to Severe Inflammatory Bowel Disease Who Failed at Least Two TNF Antagonists United European Gastroenterology Journal. Apr, 2018 | Pubmed ID: 29774158 Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 12, 2018 | Pubmed ID: 29704680 Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study Inflammatory Bowel Diseases. 04, 2018 | Pubmed ID: 29668947 The Operative Risk and Natural History After the Diagnosis of Ileal Penetrating Crohn's Disease European Journal of Gastroenterology & Hepatology. May, 2018 | Pubmed ID: 29462028 Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease Gastroenterology. 04, 2018 | Pubmed ID: 29277560 Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease Journal of Crohn's & Colitis. Mar, 2018 | Pubmed ID: 29220430 Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based Vs Trough Concentration-Based Dosing of Infliximab Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 08, 2018 | Pubmed ID: 29203225 Biopsy-derived Intestinal Epithelial Cell Cultures for Pathway-based Stratification of Patients With Inflammatory Bowel Disease Journal of Crohn's & Colitis. Jan, 2018 | Pubmed ID: 29029005 Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model Journal of Crohn's & Colitis. Jan, 2018 | Pubmed ID: 28981768 Clinical Relevance of Detecting Anti-infliximab Antibodies with a Drug-tolerant Assay: Post Hoc Analysis of the TAXIT Trial Gut. 05, 2018 | Pubmed ID: 28450388 Effect of Vedolizumab (anti-α4β7-integrin) Therapy on Histological Healing and Mucosal Gene Expression in Patients with UC Gut. 01, 2018 | Pubmed ID: 27802155 Human Intestinal Epithelium in a Dish: Current Models for Research into Gastrointestinal Pathophysiology United European Gastroenterology Journal. Dec, 2017 | Pubmed ID: 29238585 Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time Inflammatory Bowel Diseases. 12, 2017 | Pubmed ID: 29140943 The Effectiveness of Intravenous Iron for Iron Deficiency Anemia in Gastrointestinal Cancer Patients: a Retrospective Study Annals of Gastroenterology. 2017 | Pubmed ID: 29118560 Perioperative Use of Vedolizumab is Not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy Journal of Crohn's & Colitis. Oct, 2017 | Pubmed ID: 28981886 Management of Postoperative Crohn's Disease: Missing Pieces of the Puzzle Journal of Crohn's & Colitis. Oct, 2017 | Pubmed ID: 28961940 Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease Inflammatory Bowel Diseases. 10, 2017 | Pubmed ID: 28885228 Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window Inflammatory Bowel Diseases. 09, 2017 | Pubmed ID: 28816757 Evolution of Cytokines and Inflammatory Biomarkers During Infliximab Induction Therapy and the Impact of Inflammatory Burden on Primary Response in Patients with Crohn's Disease Scandinavian Journal of Gastroenterology. Oct, 2017 | Pubmed ID: 28622097 Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study Inflammatory Bowel Diseases. 09, 2017 | Pubmed ID: 28590343 A Safety Assessment of Biological Therapies Targeting the IL-23/IL-17 Axis in Inflammatory Bowel Diseases Expert Opinion on Drug Safety. Jul, 2017 | Pubmed ID: 28573876 Inhibition of Gelatinase B/MMP-9 Does Not Attenuate Colitis in Murine Models of Inflammatory Bowel Disease Nature Communications. 05, 2017 | Pubmed ID: 28561062 Development of Organoids from Mouse and Human Endometrium Showing Endometrial Epithelium Physiology and Long-term Expandability Development (Cambridge, England). 05, 2017 | Pubmed ID: 28442471 Epithelial Organoid Cultures from Patients with Ulcerative Colitis and Crohn's Disease: a Truly Long-term Model to Study the Molecular Basis for Inflammatory Bowel Disease? Gut. 12, 2017 | Pubmed ID: 28159838 Effects of Introduction of an Inflammatory Bowel Disease Nurse Position on the Quality of Delivered Care European Journal of Gastroenterology & Hepatology. Jun, 2017 | Pubmed ID: 28118176 Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease Inflammatory Bowel Diseases. 02, 2017 | Pubmed ID: 28079621 Comparison of Health-related Quality of Life and Disability in Ulcerative Colitis Patients Following Restorative Proctocolectomy with Ileal Pouch-anal Anastomosis Versus Anti-tumor Necrosis Factor Therapy European Journal of Gastroenterology & Hepatology. Mar, 2017 | Pubmed ID: 27902515 Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab The AAPS Journal. 03, 2017 | Pubmed ID: 27873119 Biological Therapy Targeting the IL-23/IL-17 Axis in Inflammatory Bowel Disease Expert Opinion on Biological Therapy. 01, 2017 | Pubmed ID: 27817215 Incidence of Renal Cell Carcinoma in Inflammatory Bowel Disease Patients with and Without Anti-TNF Treatment European Journal of Gastroenterology & Hepatology. Jan, 2017 | Pubmed ID: 27603297 Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? Journal of Crohn's & Colitis. Mar, 2017 | Pubmed ID: 27591675 A Simplified Geboes Score for Ulcerative Colitis Journal of Crohn's & Colitis. Mar, 2017 | Pubmed ID: 27571771 Submucosal Plexitis As a Predictive Factor for Postoperative Endoscopic Recurrence in Patients with Crohn's Disease Undergoing a Resection with Ileocolonic Anastomosis: Results from a Prospective Single-centre Study Journal of Crohn's & Colitis. Feb, 2017 | Pubmed ID: 27466173 Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis Journal of Crohn's & Colitis. Jan, 2017 | Pubmed ID: 27402915 Specific Members of the Predominant Gut Microbiota Predict Pouchitis Following Colectomy and IPAA in UC Gut. 01, 2017 | Pubmed ID: 26423113 A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease The American Journal of Gastroenterology. Oct, 2016 | Pubmed ID: 27481307 Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells (Cx601) for Complex Perianal Fistulas in Crohn's Disease: a Phase 3 Randomised, Double-blind Controlled Trial Lancet (London, England). Sep, 2016 | Pubmed ID: 27477896 Primary Sclerosing Cholangitis is Characterised by Intestinal Dysbiosis Independent from IBD Gut. 10, 2016 | Pubmed ID: 27207975 Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis Journal of Crohn's & Colitis. Nov, 2016 | Pubmed ID: 27194531 Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab Journal of Crohn's & Colitis. Sep, 2016 | Pubmed ID: 27022161 Letter: Smoking As a Modifiable Risk Factor for a Complicated Course in Crohn's Disease. Authors' Reply Alimentary Pharmacology & Therapeutics. Feb, 2016 | Pubmed ID: 26782115 Identifying Predictors of Low Adherence in Patients with Inflammatory Bowel Disease European Journal of Gastroenterology & Hepatology. May, 2016 | Pubmed ID: 26760588 Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis Journal of Crohn's & Colitis. May, 2016 | Pubmed ID: 26738756 Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. Apr, 2016 | Pubmed ID: 26681486 Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease Journal of Crohn's & Colitis. Apr, 2016 | Pubmed ID: 26519463 RAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice American Journal of Respiratory and Critical Care Medicine. Feb, 2016 | Pubmed ID: 26509335 Antibodies to Adalimumab Are Associated with Future Inflammation in Crohn's Patients Receiving Maintenance Adalimumab Therapy: a Post Hoc Analysis of the Karmiris Trial Gut. 07, 2016 | Pubmed ID: 25862647 Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases Inflammatory Bowel Diseases. Dec, 2015 | Pubmed ID: 26383913 A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease Journal of Crohn's & Colitis. Dec, 2015 | Pubmed ID: 26351386 Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex As a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease Journal of Crohn's & Colitis. Dec, 2015 | Pubmed ID: 26351381 Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease Inflammatory Bowel Diseases. Nov, 2015 | Pubmed ID: 26313692 Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy Inflammatory Bowel Diseases. Oct, 2015 | Pubmed ID: 26308438 The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients Journal of Crohn's & Colitis. Oct, 2015 | Pubmed ID: 26116558 Systematic Versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence Journal of Crohn's & Colitis. Aug, 2015 | Pubmed ID: 25926532 Immunogenicity to Infliximab is Associated with HLA-DRB1 Gut. Aug, 2015 | Pubmed ID: 25876612 Trough Concentrations of Infliximab Guide Dosing for Patients with Inflammatory Bowel Disease Gastroenterology. Jun, 2015 | Pubmed ID: 25724455 A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients with Ulcerative Colitis Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. Mar, 2015 | Pubmed ID: 25117777 Integrated MiRNA and MRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis PloS One. 2014 | Pubmed ID: 25546151 Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex As a Surrogate Serum Marker of Mucosal Healing in Ulcerative Colitis Inflammatory Bowel Diseases. Jul, 2014 | Pubmed ID: 24871805 Targeting TNF-α for the Treatment of Inflammatory Bowel Disease Expert Opinion on Biological Therapy. Jan, 2014 | Pubmed ID: 24206084 Drug Safety Evaluation of Certolizumab Pegol Expert Opinion on Drug Safety. Feb, 2014 | Pubmed ID: 24156537 A Decrease of the Butyrate-producing Species Roseburia Hominis and Faecalibacterium Prausnitzii Defines Dysbiosis in Patients with Ulcerative Colitis Gut. Aug, 2014 | Pubmed ID: 24021287 Validation of Endoscopic Activity Scores in Patients with Crohn's Disease Based on a Post Hoc Analysis of Data from SONIC Gastroenterology. Nov, 2013 | Pubmed ID: 23954314 Unique Gene Expression and MR T2 Relaxometry Patterns Define Chronic Murine Dextran Sodium Sulphate Colitis As a Model for Connective Tissue Changes in Human Crohn's Disease PloS One. 2013 | Pubmed ID: 23894361 Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis Inflammatory Bowel Diseases. May, 2013 | Pubmed ID: 23518809 Certolizumab Pegol in the Treatment of Crohn's Disease Expert Opinion on Biological Therapy. Apr, 2013 | Pubmed ID: 23451881 Interleukin-15 Receptor α Expression in Inflammatory Bowel Disease Patients Before and After Normalization of Inflammation with Infliximab Immunology. Jan, 2013 | Pubmed ID: 23039249 Medical Therapy and Mucosal Healing Current Drug Targets. Sep, 2012 | Pubmed ID: 22664087 Second Primary Malignancies in Patients with a Gastrointestinal Neuroendocrine Tumour: a Case Report and Review of the Literature Acta Gastro-enterologica Belgica. Jul-Sep, 2010 | Pubmed ID: 21086947 Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis Senne Cuyx1,2, Anabela S. Ramalho1, Nikky Corthout3,4, Steffen Fieuws5, Eva Fürstová6, Kaline Arnauts7,8, Marc Ferrante7,9, Catherine Verfaillie8, Sebastian Munck3,4, Mieke Boon1,2, Marijke Proesmans1,2, Lieven Dupont10,11, Kris De Boeck1,2, François Vermeulen1,2 1Department of Development and Regeneration, Woman and Child Unit, CF research lab, KU Leuven, 2Department of Pediatrics, Pediatric Pulmonology, University Hospitals Leuven, 3VIB Bio Imaging Core, VIB-KU Leuven Center for Brain & Disease Research, 4Department for Neuroscience, KU Leuven, 5Interuniversity Center for Biostatistics and Statistical Bioinformatics, University of Leuven and University of Hasselt, 6Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 7Department of Chronic Diseases and Metabolism (CHROMETA), Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, 8Department of Development and Regeneration, Stem Cell Institute Leuven (SCIL), KU Leuven, 9Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, 10Department of Chronic Diseases, Metabolism and Ageing; Pneumology, KU Leuven, 11Department of Respiratory Diseases, University Hospitals Leuven JoVE 63818 의학
Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis Senne Cuyx1,2, Anabela S. Ramalho1, Nikky Corthout3,4, Steffen Fieuws5, Eva Fürstová6, Kaline Arnauts7,8, Marc Ferrante7,9, Catherine Verfaillie8, Sebastian Munck3,4, Mieke Boon1,2, Marijke Proesmans1,2, Lieven Dupont10,11, Kris De Boeck1,2, François Vermeulen1,2 1Department of Development and Regeneration, Woman and Child Unit, CF research lab, KU Leuven, 2Department of Pediatrics, Pediatric Pulmonology, University Hospitals Leuven, 3VIB Bio Imaging Core, VIB-KU Leuven Center for Brain & Disease Research, 4Department for Neuroscience, KU Leuven, 5Interuniversity Center for Biostatistics and Statistical Bioinformatics, University of Leuven and University of Hasselt, 6Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 7Department of Chronic Diseases and Metabolism (CHROMETA), Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, 8Department of Development and Regeneration, Stem Cell Institute Leuven (SCIL), KU Leuven, 9Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, 10Department of Chronic Diseases, Metabolism and Ageing; Pneumology, KU Leuven, 11Department of Respiratory Diseases, University Hospitals Leuven JoVE 63818 의학